Advertisement

Lidocaine with Epinephrine Injection

[06 August 2015]

Products Affected - Description

Lidocaine with Epinephrine Injection

Reason for the Shortage

  • Fresenius Kabi had Xylocaine with epinephrine presentations on shortage due to increased demand for the product.
  • Hospira had lidocaine with epinephrine presentations on shortage due to manufacturing delays and increased demand.

Available Products

Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi
1%, 10 mL vial, 25 count (NDC 63323-0487-17)
1%, 30 mL vial, sterile-pack 5 count (NDC 63323-0487-31)
1%, 30 mL vial, 25 count (NDC 63323-0487-37)
1.5%, 10 mL vial, 25 count (NDC 63323-0488-17)
1.5%, 30 mL vial, sterile-pack 5 count (NDC 63323-0488-31)
1.5%, 30 mL vial, 25 count (NDC 63323-0488-37)
2%, 10 mL vial, 25 count (NDC 63323-0489-17)
2%, 20 mL vial, sterile-pack 5 count (NDC 63323-0489-21)
2%, 20 mL vial, 25 count (NDC 63323-0489-27)
 
Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi
0.5%, 50 mL vial, 25 count (NDC 63323-0481-57)
1%, 10 mL vial, 25 count (NDC 63323-0482-17)
1%, 20 mL vial, 25 count (NDC 63323-0482-27)
1%, 50 mL vial, 25 count (NDC 63323-0482-57)
2%, 20 mL vial, 25 count (NDC 63323-0483-27)
2%, 50 mL vial, 25 count (NDC 63323-0483-57)
 
Lidocaine (with epinephrine 1:200,000) injection, Hospira
0.5%, 50 mL vial, 100 count (NDC 00409-3177-01)
1.5%, 5 mL glass ampule, 10 count (NDC 00409-1209-01)
1.5%, 30 mL vial, 25 count (NDC 00409-3181-01)
2%, 20 mL vial, 25 count (NDC 00409-3183-01)
 
Lidocaine (with epinephrine 1:100,000) injection, Hospira
1%, 20 mL vial, 100 count (NDC 00409-3178-01)
1%, 30 mL vial, 100 count (NDC 00409-3178-02)
1%, 50 mL vial, 100 count (NDC 00409-3178-03)
2%, 20 mL vial, 100 count (NDC 00409-3182-01)
2%, 30 mL vial, 100 count (NDC 00409-3182-02)
2%, 50 mL vial, 100 count (NDC 00409-3182-03)

Estimated Resupply Dates

All presentations are currently available.

Related Shortages

Updated

August 6, July 17, June 25, May 11, April 15, March 27, February 3, 20, and 27, January 7 and 23, 2015; December 1, 12, and 18, November 14 and 20, October 14, September 5 and 10, August 28, July 3, 17, and 25, June 11, May 1, 12, and 28, April 9, March 7 and 27, February 7 and 27, January 6, 14, and 21, 2014; December 13, November 15 and 27, October 9 and 31, September 3 and 18, August 13, July 1, June 6, 10, and 26, May 9, April 9 and 23, March 27, February 5 and 28, January 16, 2013; December 12, November 9, October 17 and 25, August 9 and 22, June 21, May 30, April 16, March 7, February 8 and 22, January 3 and 25, 2012; December 16, November 16, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement